Son Mary Beth F, Gauvreau Kimberlee, Kim Susan, Tang Alexander, Dedeoglu Fatma, Fulton David R, Lo Mindy S, Baker Annette L, Sundel Robert P, Newburger Jane W
Division of Immunology, Boston Children's Hospital, Boston, MA
Department of Pediatrics, Harvard Medical School, Boston, MA.
J Am Heart Assoc. 2017 May 31;6(6):e005378. doi: 10.1161/JAHA.116.005378.
Accurate risk prediction of coronary artery aneurysms (CAAs) in North American children with Kawasaki disease remains a clinical challenge. We sought to determine the predictive utility of baseline coronary dimensions adjusted for body surface area ( scores) for future CAAs in Kawasaki disease and explored the extent to which addition of established Japanese risk scores to baseline coronary artery scores improved discrimination for CAA development.
We explored the relationships of CAA with baseline scores; with Kobayashi, Sano, Egami, and Harada risk scores; and with the combination of baseline scores and risk scores. We defined CAA as a maximum score (zMax) ≥2.5 of the left anterior descending or right coronary artery at 4 to 8 weeks of illness. Of 261 patients, 77 patients (29%) had a baseline zMax ≥2.0. CAAs occurred in 15 patients (6%). CAAs were strongly associated with baseline zMax ≥2.0 versus <2.0 (12 [16%] versus 3 [2%], respectively, <0.001). Baseline zMax ≥2.0 had a C statistic of 0.77, good sensitivity (80%), and excellent negative predictive value (98%). None of the risk scores alone had adequate discrimination. When high-risk status per the Japanese risk scores was added to models containing baseline zMax ≥2.0, none were significantly better than baseline zMax ≥2.0 alone.
In a North American center, baseline zMax ≥2.0 in children with Kawasaki disease demonstrated high predictive utility for later development of CAA. Future studies should validate the utility of our findings.
准确预测北美川崎病患儿冠状动脉瘤(CAA)仍然是一项临床挑战。我们试图确定根据体表面积调整的基线冠状动脉尺寸(评分)对川崎病未来发生CAA的预测效用,并探讨在基线冠状动脉评分中加入已确立的日本风险评分能在多大程度上改善对CAA发生的判别能力。
我们探讨了CAA与基线评分、小林、佐野、江上和原田风险评分以及基线评分与风险评分组合之间的关系。我们将CAA定义为发病4至8周时左前降支或右冠状动脉的最大评分(zMax)≥2.5。在261例患者中,77例(29%)基线zMax≥2.0。15例患者(6%)发生了CAA。CAA与基线zMax≥2.0和<2.0密切相关(分别为12例[16%]和3例[2%],P<0.001)。基线zMax≥2.0的C统计量为0.77,敏感性良好(80%),阴性预测值极佳(98%)。单独的风险评分均无足够的判别能力。当将日本风险评分定义的高危状态添加到包含基线zMax≥2.0的模型中时,没有一个模型比单独的基线zMax≥2.0显著更好。
在北美一个中心,川崎病患儿基线zMax≥2.0对CAA的后期发生具有较高的预测效用。未来的研究应验证我们研究结果的效用。